SignalPGx is a global pharmacogenomics reporting and medication intelligence platform built for laboratories, hospital systems, provider networks, clinics, pharmacy partners, and healthcare enterprises.
The platform helps healthcare organizations turn genotype data into clear, evidence-backed medication guidance through physician-reviewed PGx reports, SignalAI-assisted interpretation, living reanalysis, and EHR-ready integrations.
SignalPGx supports multiple genotype input formats, including VCF, Agena MassARRAY, CSV, and custom laboratory files. It currently supports 50+ pharmacogenes and approximately 950 medications with clinical PGx guidance.
At the center of the platform is the Medication Intelligence Graph, which connects gene-drug relationships, medication guidance, drug labeling, clinical evidence, and patient-specific medication context. SignalPGx also includes a Living Patient Passport, allowing PGx insights to remain useful as medications, evidence, and guidelines change over time.
Key capabilities include white-label PGx reporting, physician review workflows, SignalAI clinical interpretation support, medication simulation, living reanalysis and alerts, reimbursement documentation support, and integrations through SMART on FHIR, HL7/FHIR, CDS Hooks, and REST APIs.
SignalPGx is designed with enterprise-grade security, tenant isolation, role-based access control, audit logging, encryption, and scalable multi-region AWS infrastructure.
SignalPGx supports clinical decision-making and PGx reporting workflows but does not replace physician judgment. Prescribing decisions remain with the treating healthcare provider.
White-Label PGx Reports
Branded pharmacogenomics reports delivered under your lab, hospital, or healthcare organizationโs identity.
Physician-Reviewed Workflow
Clinical review and sign-off workflow designed for physician-reviewed PGx report release.
SignalAI Interpretation
AI-assisted, source-cited PGx interpretation support for medication guidance and clinical review.
Medication Intelligence Graph
Evidence-driven gene-drug intelligence layer connecting PGx findings, medications, clinical evidence, and labeling.
Living Patient Passport
Patient-accessible PGx profile that keeps medication guidance useful as medications, evidence, and guidelines change.
Living Reanalysis
Re-evaluates PGx results when medications, evidence, or clinical guidance changes over time.
Medication Simulator
Supports genotype-aware medication review, therapy comparison, and medication risk evaluation.
EHR Integration
Supports SMART on FHIR, HL7/FHIR, CDS Hooks, and REST API connectivity.
Genotype File Support
Supports VCF, Agena MassARRAY, CSV, and custom laboratory file formats. Feature name:
Enterprise Security
Built with tenant isolation, RBAC, audit logging, encryption, and scalable multi-region AWS infrastructure.
Reimbursement Support
Includes CPT, ICD-10, MolDX Z-code context, and audit-ready medical necessity documentation support.
Clinical Evidence Sources
Uses trusted PGx and medication evidence sources including CPIC, DPWG, FDA labels, PharmGKB, RxNorm, and DailyMed.
SignalPGx combines pharmacogenomics reporting, medication intelligence, physician-reviewed workflows, SignalAI-assisted interpretation, living reanalysis, and EHR-ready integrations in one platform.
Unlike static PGx report generators, SignalPGx is designed to keep medication guidance useful over time as medications, evidence, and clinical guidelines change. It supports white-label PGx reports, VCF, Agena MassARRAY, CSV, and custom file formats, plus integrations through SMART on FHIR, HL7/FHIR, CDS Hooks, and REST APIs.
SignalPGx also includes enterprise-grade security features such as tenant isolation, RBAC, audit logging, encryption, and scalable multi-region AWS infrastructure.
SignalPGx is built for organizations that need more than a one-time PGx PDF. It helps labs, hospital systems, provider networks, clinics, and healthcare enterprises turn genotype data into evidence-backed medication guidance with clinical review, EHR integration, and long-term reanalysis.
Key advantages include white-label reporting, physician-reviewed workflows, SignalAI interpretation support, Medication Intelligence Graph, Living Patient Passport, medication simulation, reimbursement documentation support, and modern interoperability through SMART on FHIR, HL7/FHIR, CDS Hooks, and REST APIs.
It is designed for real clinical workflows, not just report generation.
SignalPGx is built for laboratories, hospital systems, health systems, provider networks, clinics, pharmacy partners, and healthcare enterprises that want to launch or expand pharmacogenomics reporting and medication intelligence workflows.
The platform is especially useful for organizations that need physician-reviewed PGx reports, branded reporting, EHR integration, medication guidance, evidence-backed interpretation, living reanalysis, and secure enterprise deployment.
SignalPGx was created because pharmacogenomics deserves more than a static report. Many PGx workflows still depend on PDFs, manual interpretation, disconnected evidence sources, and limited EHR integration.
SignalPGx was built to turn genotype data into living medication intelligence. The platform brings together evidence-backed PGx reporting, physician-reviewed workflows, SignalAI-assisted interpretation, branded reports, EHR integrations, medication simulation, and long-term reanalysis so PGx results can remain useful after the first report is released.
The goal is simple: help healthcare organizations make PGx reporting clearer, faster, more connected, and more clinically useful.
SignalPGx uses modern cloud, interoperability, security, and clinical data technologies to support enterprise PGx reporting and medication intelligence.
Primary technologies and standards include AWS cloud infrastructure, multi-region deployment architecture, tenant isolation, role-based access control, audit logging, encryption in transit and at rest, REST APIs, SMART on FHIR, HL7/FHIR, CDS Hooks, LOINC, HGNC, RxNorm, and structured PGx data processing.
The platform also supports VCF, Agena MassARRAY, CSV, and custom laboratory file formats, with SignalAI-assisted interpretation and evidence mapping across trusted PGx and medication sources.
We have collected here some useful links to help you find out if SignalPGx is good.
Check the traffic stats of SignalPGx on SimilarWeb. The key metrics to look for are: monthly visits, average visit duration, pages per visit, and traffic by country. Moreoever, check the traffic sources. For example "Direct" traffic is a good sign.
Check the "Domain Rating" of SignalPGx on Ahrefs. The domain rating is a measure of the strength of a website's backlink profile on a scale from 0 to 100. It shows the strength of SignalPGx's backlink profile compared to the other websites. In most cases a domain rating of 60+ is considered good and 70+ is considered very good.
Check the "Domain Authority" of SignalPGx on MOZ. A website's domain authority (DA) is a search engine ranking score that predicts how well a website will rank on search engine result pages (SERPs). It is based on a 100-point logarithmic scale, with higher scores corresponding to a greater likelihood of ranking. This is another useful metric to check if a website is good.
The latest comments about SignalPGx on Reddit. This can help you find out how popualr the product is and what people think about it.
Do you know an article comparing SignalPGx to other products?
Suggest a link to a post with product alternatives.
Is SignalPGx good? This is an informative page that will help you find out. Moreover, you can review and discuss SignalPGx here. The primary details have been verified within the last quarter. So they could be considered up to date. If you think we are missing something, please use the means on this page to comment or suggest changes. All reviews and comments are highly encouranged and appreciated as they help everyone in the community to make an informed choice. Please always be kind and objective when evaluating a product and sharing your opinion.